Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways (Q33582914)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways |
scientific article |
Statements
1 reference
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways (English)
1 reference
Stefania Bruno
1 reference
Giovanni Grignani
1 reference
Giuliana Cavalloni
1 reference
Manuela Motta
1 reference
Marta Tapparo
1 reference
Alessia Bottos
1 reference
Loretta Gammaitoni
1 reference
Giorgia Migliardi
1 reference
Marco Alberghini
1 reference
Bruno Torchio
1 reference
Stefano Ferrari
1 reference
10 December 2009
1 reference
1 reference
118
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference
1 reference